Skip to main content

Luminex and Swiss Firm Tecan Co-Develop Assay System

NEW YORK, June 6-Luminex and Tecan will combine and co-market their products to create an integrated sample preparation and assay system, the two companies said today.

 

The system is expected to be available beginning in the end of 2002. At that point, the partners will co-market this system in a nonexclusive arrangement.

 

Luminex' xMAP system performs medium and high-throughput assays for pharmaceutical, diagnostics and research applications.

 

Tecan specializes in developing tools and supplies for pharmaceutical and biotechnology research. The company manufactures liquid handling instrumentation and sample preparation systems.

 

Zurich, Switzerland-based Tecan has a site in Durham, N.C.

 

For more information, see the company press release.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.